Fengfeng Xu
- Molecular Biology
- Plant Science top 10%
- Oncology
- Genetics
- Radiology, Nuclear Medicine and Imaging top 10%
- Co-authors
- Robert C. BastC. BoyerPak‐Lam YuGordon B. MillsL. E. PearceKathy O'BriantYinhua YuJeffrey B. Ulmer
- Topics
- Monoclonal and Polyclonal Antibodies Research (6 papers)HER2/EGFR in Cancer Research (5 papers)Bacterial Genetics and Biotechnology (4 papers)
- Cited by
- BiotechnologyOncologyGenetics
- Partner nations
- United StatesChinaNew Zealand
In The Last Decade
Fengfeng Xu
21 papers receiving 614 citations
Peers
Comparison fields: 5 of 63
- Molecular Biology 272
- Plant Science 183
- Oncology 168
- Genetics 152
- Radiology, Nuclear Medicine and Imaging 121
Countries citing papers authored by Fengfeng Xu
This map shows the geographic impact of Fengfeng Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengfeng Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengfeng Xu more than expected).
Fields of papers citing papers by Fengfeng Xu
This network shows the impact of papers produced by Fengfeng Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengfeng Xu. The network helps show where Fengfeng Xu may publish in the future.
Co-authorship network of co-authors of Fengfeng Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Fengfeng Xu. A scholar is included among the top collaborators of Fengfeng Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fengfeng Xu. Fengfeng Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 153 | |
| 4 | 3 | |
| 5 | 16 | |
| 6 | 30 | |
| 7 | Synergistic interaction between anti-p185HER-2 ricin A chain immunotoxins and radionuclide conjugates for inhibiting growth of ovarian and breast cancer cells that overexpress HER-2. | 11 |
| 8 | The human ARHI tumor suppressor gene inhibits lactation and growth in transgenic mice. | 29 |
| 9 | 12 | |
| 10 | 22 | |
| 11 | The outcome of heregulin-induced activation of ovarian cancer cells depends on the relative levels of HER-2 and HER-3 expression. | 58 |
| 12 | Cell surface density of p185(c-erbB-2) determines susceptibility to anti-p185(c-erbB-2)-ricin A chain (RTA) immunotoxin therapy alone and in combination with anti-p170(EGFR)-RTA in ovarian cancer cells. | 24 |
| 13 | 3 | |
| 14 | Heregulin and agonistic anti-p185(c-erbB2) antibodies inhibit proliferation but increase invasiveness of breast cancer cells that overexpress p185(c-erbB2): increased invasiveness may contribute to poor prognosis. | 61 |
| 15 | 3 | |
| 16 | 15 | |
| 17 | 35 | |
| 18 | 21 | |
| 19 | Requirements for the internalization of a murine monoclonal antibody directed against the HER-2/neu gene product c-erbB-2. | 65 |
| 20 | 12 |
About Fengfeng Xu
Fengfeng Xu is a scholar working on Virology, Endocrinology and Immunology, having authored 22 papers that have together received 638 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (6 papers), HER2/EGFR in Cancer Research (5 papers) and Bacterial Genetics and Biotechnology (4 papers). The work is most often cited by research in Biotechnology (76 citations), Oncology (168 citations) and Genetics (152 citations). Fengfeng Xu has collaborated with scholars based in United States, China and New Zealand. Frequent co-authors include Robert C. Bast, C. Boyer, Pak‐Lam Yu, Gordon B. Mills, L. E. Pearce, Kathy O'Briant, Yinhua Yu, Jeffrey B. Ulmer, Jian Hou and Yamei Wang. Their work appears in journals such as Journal of Virology, The Journal of Infectious Diseases and Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.